Cite

HARVARD Citation

    Fischer, B. et al. (2017). 'Delisting' OxyContin® to reduce prescription opioid‐related harms in Ontario (Canada)—gauging effects 5 years later. Pharmacoepidemiology and drug safety. 26 (9), pp. 1040-1043. [Online]. 
  
Back to record